Compare Manulife Financial Corporation (MFC) vs Stryker Corporation (SYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Manulife Financial Corporation vs Stryker Corporation — how do they compare? Manulife Financial Corporation trades at $43.97 (market cap $72.68B), while Stryker Corporation trades at $345.73 (market cap $133.54B). The key difference: Stryker Corporation is the larger of the two by market cap, and Manulife Financial Corporation pays the higher dividend (3.1%). Which is the better fit depends on your goals.
| MFC | SYK | |
|---|---|---|
Market Cap | $72.68B | $133.54B |
Sector | Financials | Technology |
52-Week High | $44.77 | $394.34 |
52-Week Low | $30.06 | $282.58 |
Enterprise Value | $67.84B | $145.01B |
Dividend Yield | 3.1% | 1.01% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Manulife Financial (MFC) trades at $44.09, down slightly by 0.14% today, with a neutral technical signal and mixed earnings performance. The company reported strong Q2 2026 results with 12% core earnings growth and 21% APE sales growth in Asia, though Q1 results missed expectations. Revenue has grown from $15.3B in 2022 to $53.0B in 2025, with net income margin at 11.7% and ROE of 13.88%. Recent partnerships with Microsoft and Alibaba Cloud highlight strategic AI investments.
MFC presents a balanced outlook with solid fundamentals and growth in Asian markets, supported by a 57% analyst buy rating and $51.50 price target. However, premium valuation (P/E 16.57, P/B 2.18) and mixed technical indicators suggest cautious optimism. Key risks include execution in wealth management, regulatory scrutiny in Hong Kong, and macroeconomic sensitivity. The stock offers steady dividends with recent $0.49 payouts.
Stryker (SYK) trades at $345.86, up slightly by 0.01% today, with a bullish technical signal and strong analyst support. The company reported a Q2 2026 earnings beat with $3.69 EPS versus $3.49 expected, driven by 9% organic sales growth and recovery from a cyber incident. Fundamentals show robust profitability with a 14.43% net income margin and 16.51% ROE, though valuation ratios like a P/E of 36.08 are elevated.
Outlook remains positive with raised guidance and new product launches like Mako RPS expanding market reach. Key risks include execution challenges post-cyberattack and competitive pressures. The consensus price target of $379.44 implies ~10% upside, supported by 74% buy ratings from analysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Manulife Financial Corporation
Manulife provides life insurance and wealth management products and services to individuals and group customers in Canada, the United States, and Asia. Manulife is one of Canada's Big Three Life Insurance companies (the other two are Sun Life and Great West Life). As of Dec. 31, 2021, Manulife reported assets under management or administration of about CAD $1.4 trillion.
Read more on MFC →About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →
